RETATRUTIDE 5mg (17.5% Weight Reduction at 24 Weeks)
USA Domestic & Worldwide
Buy 2 Get 1 Free

RETATRUTIDE 5mg (17.5% Weight Reduction at 24 Weeks)

£70.00

Retatrutide

Pack 1 vial x 5 mg lyophilized (freeze-dried) powder.

Note:  The following lab supplies are required for reconstitution: bacteriostatic water for mixing, and syringes to draw from the vials.

Add to wishlist

Categories: , , ,

Description

USA DOMESTIC 

International Delivery

Estimated delivery 2-3 weeks

Retatrutide Helps Patients Achieve 17.5% Weight Reduction at 24 Weeks

Retatrutide 5mg is a cutting-edge triple hormone receptor agonist designed to target extreme weight loss, appetite control, and metabolic enhancement. Each vial contains 5mg of Retatrutide, a research compound known for activating GLP-1, GIP, and glucagon receptors, resulting in powerful fat loss effects and improved metabolic regulation.

Unlike traditional GLP-1 medications like Semaglutide or Tirzepatide, Retatrutide goes a step further — combining three synergistic mechanisms into one compound. Early human trials show dramatic reductions in body weight (over 24% in some cases), improved insulin sensitivity, and reduced inflammation markers.

Retatrutide is currently under investigation but already considered one of the most promising next-gen compounds in the fight against obesity, metabolic disease, and type 2 diabetes.

What is Retatrutide?

Retatrutide is a multi-receptor peptide that stimulates:

  • GLP-1 (glucagon-like peptide-1) – Reduces appetite, slows digestion, improves insulin response

  • GIP (glucose-dependent insulinotropic polypeptide) – Enhances insulin secretion and fat metabolism

  • Glucagon receptors – Increases energy expenditure and fat oxidation

The combination of these actions supports weight loss from multiple angles, making it potentially more effective than single-pathway agents.

Benefits of Retatrutide:

  • Rapid and sustained fat loss

  • Strong appetite suppression

  • Improved insulin sensitivity

  • Supports better blood sugar regulation

  • Promotes energy expenditure and thermogenesis

  • May reduce inflammation and cardiovascular risk

  • Once-weekly dosing convenience

  • Ideal for research use in metabolic and obesity studies

How to Use:

For research purposes only. Not for human use.

  • Reconstitute with bacteriostatic water as needed

  • Typical research dosing ranges between 0.5mg to 1mg weekly, based on current data

  • Store the vial in a refrigerator (2–8°C) after reconstitution

  • Use sterile practices and research-safe materials at all times

Warnings & Precautions:

  • Retatrutide is not approved for human consumption

  • May cause nausea, gastrointestinal upset, or hypoglycemia in research models

  • Long-term effects not yet fully studied — use with appropriate safety protocols

  • Avoid mixing with other research peptides unless stability is confirmed

What You Get:

  • 1 x Vial of Retatrutide 5mg (Peptide Form)

  • High-purity research-grade product

Related products